Real-time enrollment status for this hepatocellular carcinoma recurrent clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT07118202 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma Recurrent |
| Phase | Clinical Trial |
| Target Enrollment | 198 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Barbara Ann Karmanos Cancer Institute |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 13, 2026: Clinical trial NCT07118202 is currently recruiting participants. This clinical trial study for hepatocellular carcinoma recurrent is actively seeking new participants at 6 locations across the United States. The study is sponsored by Barbara Ann Karmanos Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07118202 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07118202 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.